Ahlstrom, a global leader in fiber-based specialty materials, has acquired EBF, based in Greenville, SC. EBF is recognized for its expertise in manufacturing high-quality, natural fiber-based medical devices for the efficient collection and preservation of biological samples. With decades of experience, EBF is the leading provider of newborn screening devices, including 903 diagnostic cards and procedure packs.

This acquisition strengthens Ahlstrom’s position in the life science market and enables the company to supply high-quality materials for the rapidly growing blood and urine testing segments, including newborn screening. With EBF’s expertise in advanced printing, sequential numbering and custom packaging, Ahlstrom can now deliver specialty materials and converting solutions that are essential for a wide range of diagnostic tests. This marks a key milestone on Ahlstrom’s growth transformation journey and supports its vision to be the sustainable specialty materials company.

EBF will become part of Ahlstrom’s Filtration and Life Sciences business and will be key to the company’s lab and life sciences growth strategy.

“EBF’s high-quality business and technical capabilities are a perfect fit for our growth ambitions. This acquisition represents a step forward in the value chain for Ahlstrom, significantly adding to our converting capabilities and expanding our expertise in card manufacturing. By integrating EBF, Ahlstrom can offer more comprehensive solutions to our customers and further strengthen our position in the diagnostic testing market,” says Daniele Borlatto, EVP for Filtration and Life Sciences at Ahlstrom.

“We are thrilled to join Ahlstrom, a global leader whose resources and worldwide presence will enable us to expand our product portfolio and reach new markets,” says Brad Nelson, CEO at EBF.